Onkure Therapeutics, Stock Market Value
| OKUR Stock | 15.48 0.07 0.45% |
| Symbol | OnKure |
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OnKure Therapeutics,. If investors know OnKure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OnKure Therapeutics, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of OnKure Therapeutics, is measured differently than its book value, which is the value of OnKure that is recorded on the company's balance sheet. Investors also form their own opinion of OnKure Therapeutics,'s value that differs from its market value or its book value, called intrinsic value, which is OnKure Therapeutics,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OnKure Therapeutics,'s market value can be influenced by many factors that don't directly affect OnKure Therapeutics,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OnKure Therapeutics,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if OnKure Therapeutics, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OnKure Therapeutics,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
OnKure Therapeutics, 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to OnKure Therapeutics,'s stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of OnKure Therapeutics,.
| 07/05/2023 |
| 11/26/2024 |
If you would invest 0.00 in OnKure Therapeutics, on July 5, 2023 and sell it all today you would earn a total of 0.00 from holding OnKure Therapeutics, or generate 0.0% return on investment in OnKure Therapeutics, over 510 days. OnKure Therapeutics, is related to or competes with Vivani Medical, Verve Therapeutics, Bright Minds, Alpha Tau, Vanda Pharmaceuticals, Verrica Pharmaceuticals, and Verona Pharma. OnKure Therapeutics, is entity of United States More
OnKure Therapeutics, Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure OnKure Therapeutics,'s stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess OnKure Therapeutics, upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.9 | |||
| Information Ratio | (0.02) | |||
| Maximum Drawdown | 15.91 | |||
| Value At Risk | (6.69) | |||
| Potential Upside | 5.88 |
OnKure Therapeutics, Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for OnKure Therapeutics,'s investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as OnKure Therapeutics,'s standard deviation. In reality, there are many statistical measures that can use OnKure Therapeutics, historical prices to predict the future OnKure Therapeutics,'s volatility.| Risk Adjusted Performance | 0.0214 | |||
| Jensen Alpha | 0.0887 | |||
| Total Risk Alpha | (0.52) | |||
| Sortino Ratio | (0.02) | |||
| Treynor Ratio | (0.19) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of OnKure Therapeutics,'s price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
OnKure Therapeutics, Backtested Returns
Currently, OnKure Therapeutics, is somewhat reliable. OnKure Therapeutics, maintains Sharpe Ratio (i.e., Efficiency) of 0.0433, which implies the firm had a 0.0433% return per unit of volatility over the last 3 months. We have found twenty-nine technical indicators for OnKure Therapeutics,, which you can use to evaluate the volatility of the company. Please check OnKure Therapeutics,'s risk adjusted performance of 0.0214, and Semi Deviation of 3.48 to confirm if the risk estimate we provide is consistent with the expected return of 0.15%. OnKure Therapeutics, has a performance score of 3 on a scale of 0 to 100. The company holds a Beta of -0.29, which implies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning OnKure Therapeutics, are expected to decrease at a much lower rate. During the bear market, OnKure Therapeutics, is likely to outperform the market. OnKure Therapeutics, right now holds a risk of 3.52%. Please check OnKure Therapeutics, maximum drawdown, as well as the relationship between the skewness and day typical price , to decide if OnKure Therapeutics, will be following its historical price patterns.
Auto-correlation | -0.1 |
Very weak reverse predictability
OnKure Therapeutics, has very weak reverse predictability. Overlapping area represents the amount of predictability between OnKure Therapeutics, time series from 5th of July 2023 to 16th of March 2024 and 16th of March 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of OnKure Therapeutics, price movement. The serial correlation of -0.1 indicates that less than 10.0% of current OnKure Therapeutics, price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.1 | |
| Spearman Rank Test | 0.26 | |
| Residual Average | 0.0 | |
| Price Variance | 1.92 |
OnKure Therapeutics, lagged returns against current returns
Autocorrelation, which is OnKure Therapeutics, stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting OnKure Therapeutics,'s stock expected returns. We can calculate the autocorrelation of OnKure Therapeutics, returns to help us make a trade decision. For example, suppose you find that OnKure Therapeutics, has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
OnKure Therapeutics, regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If OnKure Therapeutics, stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if OnKure Therapeutics, stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in OnKure Therapeutics, stock over time.
Current vs Lagged Prices |
| Timeline |
OnKure Therapeutics, Lagged Returns
When evaluating OnKure Therapeutics,'s market value, investors can use the concept of autocorrelation to see how much of an impact past prices of OnKure Therapeutics, stock have on its future price. OnKure Therapeutics, autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, OnKure Therapeutics, autocorrelation shows the relationship between OnKure Therapeutics, stock current value and its past values and can show if there is a momentum factor associated with investing in OnKure Therapeutics,.
Regressed Prices |
| Timeline |
Pair Trading with OnKure Therapeutics,
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if OnKure Therapeutics, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OnKure Therapeutics, will appreciate offsetting losses from the drop in the long position's value.Moving against OnKure Stock
| 0.6 | VINC | Vincerx Pharma | PairCorr |
| 0.57 | SRZNW | Surrozen Warrant | PairCorr |
| 0.5 | VRCA | Verrica Pharmaceuticals | PairCorr |
| 0.46 | VNDA | Vanda Pharmaceuticals | PairCorr |
| 0.45 | DRMA | Dermata Therapeutics | PairCorr |
The ability to find closely correlated positions to OnKure Therapeutics, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace OnKure Therapeutics, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back OnKure Therapeutics, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling OnKure Therapeutics, to buy it.
The correlation of OnKure Therapeutics, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as OnKure Therapeutics, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if OnKure Therapeutics, moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for OnKure Therapeutics, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for OnKure Stock Analysis
When running OnKure Therapeutics,'s price analysis, check to measure OnKure Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OnKure Therapeutics, is operating at the current time. Most of OnKure Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of OnKure Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OnKure Therapeutics,'s price. Additionally, you may evaluate how the addition of OnKure Therapeutics, to your portfolios can decrease your overall portfolio volatility.